TMO ramps up acquisitions and product launches to drive growth, but heavy debt and currency headwinds raise questions for ...
Thermo Fisher Scientific (TMO) is back in focus after enrolling the first patient in its PPD CorEvitas Obesity Registry, a ...
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO) announced AI utilization plans with OpenAI in a collaboration intended to improve drug development. As part of this collaboration, Thermo ...
Thermo Fisher Scientific is well-positioned for growth due to its consistent revenue streams, strong M&A track record and minimal macroeconomic dependence. Despite a COVID-related revenue surge and ...